Impact News +++ Alkami Technology GAAP EPS of -$0.14 misses by $0.02, revenue of $113M misses by $0.48M (SeekingAlpha) +++ ALKAMI Aktie -11,96%

Gewinn & Umsatz News zur KENVUE Aktie

>KENVUE Aktienkurs

12.424 EUR -0.4% (Tradegate)

Ask: 12.37 EUR / 806 Stück

Bid: 12.166 EUR / 823 Stück

Tagesumsatz: 19215 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

KENVUE Aktie über LYNX handeln

Intraday

1 Jahr

>KENVUE Performance

1 Woche: -2,2%

1 Monat: -7,8%

3 Monate: -33,2%

6 Monate: -37,7%

1 Jahr: -39,0%

laufendes Jahr: -37,6%

>KENVUE Aktie

Name:

KENVUE INC. DL -,001

Land:

USA

Sektor:

Konsumgueter / Gastronomie

ISIN/ Wkn:

US49177J1025 / A3EEHU

Symbol/ Ticker:

J4D (Frankfurt) / KVUE (NYSE)

Kürzel:

FRA:J4D, ETR:J4D, J4D:GR, NYSE:KVUE

Index:

Webseite:

https://www.kenvue.com/

Profil:

Kenvue Inc. is a consumer healthcare and pharmaceu..
>Volltext..

Marktkapitalisierung:

24840.2 Mio. EUR

Unternehmenswert:

31351.61 Mio. EUR

Umsatz:

12997.09 Mio. EUR

EBITDA:

2854.86 Mio. EUR

Nettogewinn:

1217.14 Mio. EUR

Gewinn je Aktie:

0.64 EUR

Schulden:

7505.39 Mio. EUR

Liquide Mittel:

918.43 Mio. EUR

Operativer Cashflow:

1794.8 Mio. EUR

Bargeldquote:

0.18

Umsatzwachstum:

-11.02%

Gewinnwachstum:

15.22%

Dividende je Aktie:

0.71 EUR

Dividendenrendite:

5.45%

Dividendenschätzung:

5.5%

Div. Historie:

13.08.25 - 0.17803499€
14.05.25 - 0.17589€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

KENVUE

Letzte Datenerhebung:

30.10.25

>KENVUE Kennzahlen

Aktien/ Unternehmen:

Aktien: 1919.07 Mio. St.

Frei handelbar: 99.95%

Leerverk. Aktien: 1.51%

Rückkaufquote: 0.94%

Mitarbeiter: 22000

Umsatz/Mitarb.: 0.6 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 38.38%

Bewertung:

KGV: 19.99

KGV lG: 14.14

KUV: 1.91

KBV: 2.63

PEG-Ratio: 0.78

EV/EBITDA: 10.98

Rentabilität:

Bruttomarge: 58.12%

Gewinnmarge: 9.36%

Operative Marge: 17.95%

Managementeffizenz:

Gesamtkaprendite: 5.29%

Eigenkaprendite: 13.56%

>KENVUE Peer Group

Es sind 269 Aktien bekannt.

>KENVUE Chart & Kurs - NYSE

>KENVUE Gewinn & Umsatz News

23.10.25 - 09:24	Kenvue′s Quarterly Earnings Preview: What You Need to Know (Barchart)
	Kenvue is expected to announce its third-quarter results by early November, and analysts expect a notable decline in earnings....

03.10.25 - 21:36	Operative Herausforderungen: Moody′s stuft Kenvue-Ausblick auf "negativ" herab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 14:48	Kenvue Cuts Outlook on Weak Demand as Brand Review Continues (Bloomberg)
	Kenvue Inc. slashed its full-year sales target as demand continued to deteriorate and the company searches for a new chief executive officer to help reset the business....

07.08.25 - 14:48	ROUNDUP: Kenvue Q2 Profit Beats Market, Sales Miss; Cuts FY25 Outlook (AFX)
	WASHINGTON (dpa-AFX) - Consumer health company Kenvue, Inc. (KVUE), while reporting second-quarter profit above market estimates and net sales below the Street, on Thursday trimmed its fiscal 2025......

07.08.25 - 13:48	Kenvue Inc. Announces Advance In Q2 Profit (AFX)
	WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) revealed a profit for its second quarter that Increases, from last yearThe company's bottom line totaled $420 million, or $0.22 per share. This compares w......

07.08.25 - 13:09	Kenvue shares fall as Q2 results miss estimates, company cuts guidance (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.25 - 10:30	Kenvue Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Kenvue has outpaced the broader market over the past year, and analysts remain cautiously optimistic about the stock's prospects....

16.07.25 - 19:36	Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing (Barchart)
	Kenvue, which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually......

16.07.25 - 13:42	Kenvues Q2 2025 Earnings: What to Expect (Barchart)
	Kenvue is expected to release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip....

08.05.25 - 15:24	Kenvue Boosts 2025 Sales Growth View (WSJ EN)
	The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the year, while warning that foreign exchange would weigh on adjusted earnings....

08.05.25 - 14:16	Kenvue first-quarter results beat estimates helped by strong demand for self care products (Reuters EN)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

08.05.25 - 13:42	ROUNDUP: Kenvue Boosts FY25 Net Sales Outlook: Appoints Amit Banati To Succeed Paul Ruh As CFO (AFX)
	WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Thursday, consumer health company Kenvue, Inc. (KVUE) boosts net sales growth guidance for the full-year 2025. Adj......

08.05.25 - 13:18	Kenvue Inc. Q1 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) announced a profit for its first quarter that increased from the same period last year and beat the Street estimates.The company's bottom line totaled $32......

08.05.25 - 13:12	Kenvue′s Q2 earnings, revenue beat expectations (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

23.04.25 - 10:06	Kenvue Earnings Preview: What to Expect (Barchart)
	Kenvue is set to unveil its Q1 results in the upcoming month, and analysts expect a notable decline in earnings....

06.02.25 - 14:30	ROUNDUP: Kenvue Q4 Profit Meets Market; Sees FY25 Adj. EPS In Line Or Above Last Year (AFX)
	WASHINGTON (dpa-AFX) - Pure-play consumer health company Kenvue Inc. (KVUE) , while reporting weak fourth-quarter profit, in line with market, on Thursday issued fiscal 2025 outlook. In the pre-ma......

06.02.25 - 13:18	Kenvue Inc. Q4 Profit Drops, Inline With Estimates (AFX)
	WASHINGTON (dpa-AFX) - Kenvue Inc. (KVUE) reported a profit for fourth quarter that decreased from last year in line with the Street estimates.The company's earnings came in at $293 million, or $0......

06.02.25 - 13:15	Kenvue stock slides after missing Q4 estimates (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

06.02.25 - 13:06	Kenvue Sales Miss Estimates as Weak Volumes Plague Tylenol Maker (Bloomberg)
	Kenvue Inc., the owner of Tylenol and Band-Aid, reported sales that missed analyst estimates after weaker-than-expected volumes hurt results and provided activist investor Starboard Value with more fodder in its fight to shake up the company....

24.01.25 - 14:00	What You Need to Know Ahead of Kenvues Earnings Release (Barchart)
	Kenvue will release its fourth-quarter earnings next month, and analysts anticipate a double-digit profit dip....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Der Gelobte glaubt an die Kompetenz der Jury. - Dr. Fritz P. Rinnhofer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram